Value
5.0/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 7.0 |
| P/S | 5.6 |
| EV/EBITDA | 4.6 |
| Fwd P/E | 7.9 |
| PEG | 1.0 |
- ▸Forward P/E: 15.3x
- ▸PEG: 9.63
XZO · Why this verdict
Why Exzeo Group (XZO) is rated BUY WAIT
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictBUY WAIT
Overall score6.3/10
ConfidenceHIGH
MacroRISK_OFF
TrendMatrix Research · core thesis
Engine thesis — one sentence
Exzeo Group is a high-quality diversified insurance company with exceptional ROE of 59%, operating margins of 38%, and a Piotroski F-Score of 8 out of 9, while analysts project 66% upside to a consensus target near $22—though light analyst coverage and weak growth temper the near-term confidence.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
With a consensus analyst price target near $22.10 against a current price of $13.29, the implied upside of 66.3% is one of the largest in the screened universe, supported by a forward P/E of 11.6x and peer-relative value and quality rankings that validate the undervaluation thesis. Sentiment breakdown | Price rises above $18, closing more than 35% of the gap toward the analyst target of $22.10 within 12 months. | →Stable |
| CounterOnly 2 analysts cover the stock, making the 66% upside target statistically fragile—a single analyst revision could dramatically shift the consensus and eliminate the apparent discount. | ||
A debt-to-equity ratio of 2.5 creates a leverage penalty in the quality assessment, which is notable for a smaller insurer with a $1.2 billion market cap where leverage amplifies the impact of underwriting losses if claims experience deteriorates. Bear case | Debt-to-equity falls below 2.0 within 12 months as strong cash generation is applied toward balance sheet reduction. | ↓Deteriorating |
| CounterInsurance companies routinely carry leverage as part of the float-funded business model, and a 2.5x ratio may be appropriate for the specific lines of insurance Exzeo underwrites. | ||
An ROE of 59% and operating margins of 38% place Exzeo in the top tier of its insurance peer group, ranking best-in-class for both ROE and margins versus direct competitors, and confirming a high-quality business generating strong returns on equity deployed. Quality breakdown | ROE remains above 40% and operating margins stay above 30% over the next 12 months as the underwriting discipline that produced these results continues. | →Stable |
| CounterInsurance companies with extremely high ROE ratios can be exposed to catastrophic loss events that rapidly compress margins, and the diversified insurance label provides limited information about the specific lines of business and their tail-risk profiles. | ||
The available earnings data shows a 25% positive surprise in the most recent quarter and an inline result before that, suggesting management is executing ahead of modest consensus expectations, though only 2 quarters of history are available. Earnings | Earnings beats continue in at least 2 of the next 4 quarters with average positive surprise above 10%. | ↑Improving |
| CounterWith only 2 quarters of earnings history in the data, the beat pattern is statistically insufficient to establish a trend, and one miss could reset expectations sharply. | ||
With a consensus analyst price target near $22.10 against a current price of $13.29, the implied upside of 66.3% is one of the largest in the screened universe, supported by a forward P/E of 11.6x and peer-relative value and quality rankings that validate the undervaluation thesis.
→StableSentiment breakdown
- Expectation
- Price rises above $18, closing more than 35% of the gap toward the analyst target of $22.10 within 12 months.
CounterOnly 2 analysts cover the stock, making the 66% upside target statistically fragile—a single analyst revision could dramatically shift the consensus and eliminate the apparent discount.
A debt-to-equity ratio of 2.5 creates a leverage penalty in the quality assessment, which is notable for a smaller insurer with a $1.2 billion market cap where leverage amplifies the impact of underwriting losses if claims experience deteriorates.
↓DeterioratingBear case
- Expectation
- Debt-to-equity falls below 2.0 within 12 months as strong cash generation is applied toward balance sheet reduction.
CounterInsurance companies routinely carry leverage as part of the float-funded business model, and a 2.5x ratio may be appropriate for the specific lines of insurance Exzeo underwrites.
An ROE of 59% and operating margins of 38% place Exzeo in the top tier of its insurance peer group, ranking best-in-class for both ROE and margins versus direct competitors, and confirming a high-quality business generating strong returns on equity deployed.
→StableQuality breakdown
- Expectation
- ROE remains above 40% and operating margins stay above 30% over the next 12 months as the underwriting discipline that produced these results continues.
CounterInsurance companies with extremely high ROE ratios can be exposed to catastrophic loss events that rapidly compress margins, and the diversified insurance label provides limited information about the specific lines of business and their tail-risk profiles.
The available earnings data shows a 25% positive surprise in the most recent quarter and an inline result before that, suggesting management is executing ahead of modest consensus expectations, though only 2 quarters of history are available.
↑ImprovingEarnings
- Expectation
- Earnings beats continue in at least 2 of the next 4 quarters with average positive surprise above 10%.
CounterWith only 2 quarters of earnings history in the data, the beat pattern is statistically insufficient to establish a trend, and one miss could reset expectations sharply.
Per-dimension breakdown
Quality
8.5/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 10.0 |
| ROA | 10.0 |
| Gross margin | 10.0 |
| Op margin | 10.0 |
| Net margin | 10.0 |
| Current ratio | 6.6 |
| FCF quality | 5.9 |
| Moat | 8.4 |
| Rule of 40 | 5.5 |
| Piotroski F | 8.9 |
- ▸Excellent ROE: 50%
- ▸Strong margins: 38%
- ▸Earnings quality warning: 79% FCF/NI
- ▸Wide economic moat
Growth
5.1/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 4.2 |
| EPS growth | 6.0 |
Momentum
7.3/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.4 |
| MACD | 9.2 |
| OBV | 10.0 |
| MA position | 8.0 |
| Volume | 5.0 |
- ▸Overbought (RSI 71)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-MA but MA slope flat
Sentiment
7.0/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 6.4 |
| Price target | 9.5 |
| erm sentiment | 5.0 |
- ▸Light analyst coverage (2.0) — signal dampened
- ▸Analyst upside: 48%
Insider
7.3/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 10.0 |
| notable moves | 7.0 |
- ▸No net insider activity — $0 (0.000% of mkt cap)
- ▸Institutions accumulating
Peer rank
5.8/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 0.8 |
| quality rank | 9.2 |
| growth rank | 4.2 |
- ▸Superior ROE vs peers
- ▸Best-in-class margins
Technical
2.5/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.5 |
| support resistance | 0.2 |
| 52w position | 4.3 |
| gap | 5.0 |
Risk (lower is worse)
5.3/10data confidence 80%| Component | Sub-score |
|---|---|
| short interest | 2.6 |
| days to cover | 6.6 |
| volatility | 2.1 |
| debt equity | 9.9 |
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
7.5/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 10.0 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
- ▸Earnings in 6 days
How the verdict was assembled
Engine trigger
Wide-moat business. Accumulate on weakness.
Engine technical detail
verdict_path:
L4:PATH_E_WIDE_MOAT|ENTRY_STICKY:WITHIN_BANDPassed (7)
- MOMENTUM:7.3>=5.5
- ASYMMETRY:1.7>=1.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- EARNINGS_PROXIMITY:6d<=7d
Warning (0)
none
Reward-to-Risk
1.71
Upside
+25.6%
Downside
15.0%
Sizing output
STARTER
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — MCap $1.6B<$5B
Investment implication
The STRONG_BUY_WAIT verdict reflects the EARNINGS_PROXIMITY gate's 6d<=7d outcome against Quality at 8.5 and asymmetric R:R of 1.71.
The strongest dimensions are Quality at 8.5, Catalyst at 7.5, and Momentum at 7.3; the weakest are Technical at 2.5, Value at 5.0, and Growth at 5.1. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of 1.71 and an engine sizing output of STARTER.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Exceptional Roe And Margins
Trip ifROE falls below 30%, declining more than 49 percentage points from the current 59% level.
- P266pct Analyst Upside Gap
Trip ifAnalyst consensus price target falls below $16, declining more than 27% from the current approximately $22 target.
- P3Earnings Beat With Thin History
Trip ifEPS surprise falls below negative 10% in at least 2 of the next 4 quarters.
- P4Leverage Drag On Smaller Insurer
Trip ifDebt-to-equity ratio rises above 4.0, increasing more than 60% above the current 2.5x level.